5 rezilta yo
SEQUENCE LISTING
The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created Dec. 17, 2010, is named 69662403.txt and is 65,657 bytes in size.
FIELD OF THE INVENTION
The
FIELD OF THE INVENTION
The present invention is directed to specific cytokine antagonists, including TNF antagonists and IL-1 antagonists, for the treatment of hearing loss, including sensorineural hearing loss and presbycusis. The invention also includes methods of administration for these
TECHNICAL FIELD
The present disclosure relates generally to platinum-based chemotherapy agents, and in particular to methods and compositions for treating or preventing side effects of platinum-based chemotherapy agents in cancer treatment, and to treat or prevent inflammatory pain.
BACKGROUND OF
TECHNICAL FIELD
The present disclosure relates generally to platinum-based chemotherapy agents, and in particular to methods and compositions for treating or preventing side effects of platinum-based chemotherapy agents in cancer treatment, and to treat or prevent inflammatory pain.
BACKGROUND OF
FIELD OF THE INVENTION
A therapeutic composition for the relief and prevention of symptoms associated with ear disorders in humans and animals.
BACKGROUND OF THE INVENTION
Most ear disorders are the result of an inflammatory response to infections, allergic reactions, or trauma. The infection may be